Anant Pharmaceuticals Private Limited

Anant Pharmaceuticals Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2005PTC151401 Incorporated 18 February 2005 ROC Mumbai HQ Ambernath, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹6.76 Cr
▲ 7% YoY
Net profit · FY 2025
₹5.41 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹94.69 Lakh
EBITDA margin 14%
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹11.92 Lakh
Issued & subscribed
Open charges
₹5.74 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Employees · EPFO
40
Provident fund records

About Anant Pharmaceuticals Private Limited

Data last updated:

Anant Pharmaceuticals Private Limited is a private limited company based in Ambernath, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 February 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2005PTC151401. Its GSTIN is 27AAFCA2392F1ZS (Maharashtra).

The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹11.92 Lakh. It is led by directors including Ajit Anil Godbole (Managing Director) and Anupama Ajit Godbole.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. W / 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.76 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.41 Lakh (net margin 0.8%) and EBITDA of ₹94.69 Lakh (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 11% over five years.

The company has about 40 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Anantlabs. As per MCA filings, the company has open charges of ₹5.74 Cr on record.

Anant Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0090382). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anantlabs.com.

Company details

CIN U24100MH2005PTC151401
Registration Number 151401
Incorporation Date 18 February 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0090382

Recognitions & Rankings of Anant Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0090382

Contact details

Anant Pharmaceuticals Private Limited's registered office is in Ambernath, Maharashtra. Its website is anantlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. W / 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Anant Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Anant Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Anant Pharmaceuticals operates one associated brand: Anantlabs. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures API impurities and offers custom research and analytical services.anantlabs.com

Business activity

The main business activity of Anant Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Anant Pharmaceuticals Private Limited, buy the company report.

Financials of Anant Pharmaceuticals Private Limited

FY 2025 filings available

Anant Pharmaceuticals Private Limited reported revenue of ₹6.76 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹6.76 Cr ▲ 7%
Net profit · FY 2025
₹5.41 Lakh margin 0.8%
EBITDA · FY 2025
₹94.69 Lakh margin 14%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 5%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 2%
5 years · compounded
▲ 26%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹94.69 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.41 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Anant Pharmaceuticals Private Limited, buy the company report.

Board of directors of Anant Pharmaceuticals Private Limited

Anant Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anupama Ajit GodboleDirector18 Feb 200521 Years 8 MonthsCurrent
Ajit Anil GodboleManaging Director10 Feb 201016 Years 8 MonthsCurrent
Anil Shankar GodboleDirector18 Feb 200521 Years 8 MonthsCurrent

Peer comparison

Anant Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Gliesse Pharmaceuticals Private Limited₹6.78 Cr (FY 2025)22.0%Ahmedabad, Gujarat, India
Sanora Pharmaceuticals Private Limited₹6.77 Cr (FY 2025)39.0%Mumbai, Maharashtra, India
Anant Pharmaceuticals Private Limitedthis company₹6.76 Cr (FY 2025)₹5.41 Lakh0.8%7.0%40Ambernath, Maharashtra, India
Samnova Pharmaceuticals Private Limited₹6.74 Cr (FY 2025)55.0%Ahmedabad, Gujarat, India
HTS Biopharma Private Limited₹6.71 Cr (FY 2024)7.0%Hyderabad, Telangana, India

To see the full peer comparison of Anant Pharmaceuticals Private Limited, buy the company report.

Auditor

Anant Pharmaceuticals Private Limited is audited by K P Mehendale and Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K P Mehendale and CoFY 2023140086

Shareholding

The shareholding of Anant Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Anant Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.74 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.74 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jul 2025101141716Others₹25 LakhOpen
16 Aug 2024100962099Others₹59 LakhOpen
01 Jan 2024100850260Others₹25 LakhOpen
14 Mar 2023100691972Others₹25 LakhOpen
31 Dec 2022100673067Others₹30 LakhOpen

To see the full charge records of Anant Pharmaceuticals Private Limited, buy the company report.

Total charge records: 10 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Anant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Anant Pharmaceuticals Private Limited has a workforce of 40 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
40
Active EPFO establishments
1

GST

Anant Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAFCA2392F1ZSMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Anant Pharmaceuticals Private Limited, buy the company report.

Recent activity

Anant Pharmaceuticals Private Limited has 6 board changes on record since 2005: 3 appointments and 3 cessations. The latest: Madhavi Anil Godbole ceased to be Director on 24 May 2024.

AGM
Anant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 101141716 was registered on 30 Jul 2025.
Filing
Anant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 59.00 Lakh with Charge ID 100962099 was registered on 16 Aug 2024.
Ceased
Madhavi Anil Godbole ceased to be Director.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100850260 was registered on 01 Jan 2024.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100691972 was registered on 14 Mar 2023.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100673067 was registered on 31 Dec 2022.
Charges
A charge with Others of Rs. 45.00 Lakh registered on 09 Feb 2021 with Charge ID 100419446 was modified on 23 Mar 2021.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 100419446 was registered on 09 Feb 2021.
Charges
A charge with Others of Rs. 50.00 Lakh registered on 21 Nov 2019 with Charge ID 100305893 was modified on 31 Dec 2019.
Charges
A charge with Others of Rs. 125.00 Lakh registered on 01 Jan 2013 with Charge ID 10400202 was modified on 31 Dec 2019.

11 earlier events are in the company report.

Frequently asked questions

Anant Pharmaceuticals is an active private limited company based in Ambernath, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 February 2005 (21+ years old) and is registered under CIN U24100MH2005PTC151401.

Anant Pharmaceuticals has 3 current directors:

The latest financial statements of Anant Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Anant Pharmaceuticals is 27AAFCA2392F1ZS, registered in Maharashtra.

The CIN (Corporate Identification Number) of Anant Pharmaceuticals is U24100MH2005PTC151401. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Anant Pharmaceuticals was incorporated on 18 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Anant Pharmaceuticals by revenue are Gliesse Pharmaceuticals Private Limited, Sanora Pharmaceuticals Private Limited, Samnova Pharmaceuticals Private Limited, HTS Biopharma Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Madhavi Anil Godbole ceased to be Director on 24 May 2024. Ajit Anil Godbole ceased to be Director on 29 Sep 2012. Anil Shankar Godbole ceased to be Managing Director on 29 Sep 2012. Anant Pharmaceuticals has 6 board changes on record in total.

Yes, Anant Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0090382).

Anant Pharmaceuticals can be reached through the website anantlabs.com. Its registered office is in Ambernath, Maharashtra, India.

The registered office of Anant Pharmaceuticals is at Plot No. W 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507.